GitLife Biotech is pioneering the future of synthetic biology, aiming to set the global standard for the management of biological assets. They have introduced CellRepoTM, the world's first Version Control System for Synthetic Biology, a system that logs every change made to a biological strain in detail and assigns a unique barcode, allowing for the retrieval of specific versions at any time from a simple sequencing reaction.

GitLife Biotech’s proprietary DNA GenosignaturesTM ensure the absolute integrity of biological assets, providing proof of ownership, clear records of provenance, and robust traceability. They’re fostering collaboration across governmental, commercial, academic, and NGO entities, with CellRepo platform enabling global visibility and collaboration on engineering biology projects.

GitLife Biotech is seeking to revolutionizing the way biological assets are managed, tracked, and collaborated on, unlocking the full potential of synthetic biology worldwide.